⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HRZN News
Horizon Technology Finance Corporation
Form 8-K
sec.gov
HTFC
HRZN
Rare Disease Treatment (2026-2031) - Expanding Orphan Drug Development Drives Market Growth
globenewswire.com
JNJ
AMGN
PFE
BMY
VRTX
BMRN
ULTA
REGN
SRPT
HRZN
PTC
Form 8-K
sec.gov
HRZN
HTFC
Form 8-K
sec.gov
HRZN
HTFC
Horizon Technology Finance Announces Regular Monthly Distributions for October, November and December 2026 Totaling $0.18 per Share and Special Distributions for October, November and December 2026 Totaling $0.09 per Share
businesswire.com
HRZN
Horizon Technology Finance to Announce Second Quarter 2026 Financial Results
businesswire.com
HRZN
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
prnewswire.com
HRZN
NVS
MRK
Form 8-K
sec.gov
HRZN
HTFC
Form 8-K
sec.gov
HRZN
HTFC
Form 8-K
sec.gov
HTFC
HRZN